Immunity in medicine.
Saeed
M
M
Department of Biological and Biomedical Sciences, The Aga Khan University, Karachi.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D000068818:Cetuximab; D005260:Female; D000077156:Gefitinib; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D008297:Male; D011379:Prognosis; D011799:Quinazolines / Q000627:therapeutic use; D018570:Risk Assessment; D015996:Survival Rate; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D011799:Quinazolines; D000068818:Cetuximab; D000077156:Gefitinib